Australian firm Bionic Vision Technologies (BVT) has scored a AUS$23m ($18m) cash investment from Hong Kong-based backers to advance its retinal implant aimed at restoring vision to the blind.
BVT said it would use the funds to begin human clinical trials of its "bionic eye" in patients with the inherited degenerative eye condition, retinitis pigmentosa. "The first thing we...